Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Insight Services | PRODUCT CODE: 2023539

Cover Image

PUBLISHER: Global Insight Services | PRODUCT CODE: 2023539

AI In Radiology Market Analysis and Forecast to 2035: Type, Services, Technology, Application, Deployment, End User, Solution

PUBLISHED:
PAGES: 350 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4750
PDF & Excel (Site License)
USD 5750
PDF & Excel (Enterprise License)
USD 6750

Add to Cart

The global AI in Radiology market is projected to grow from $32.0 billion in 2025 to $249.1 billion by 2035, at a compound annual growth rate (CAGR) of 18.6%. Adoption is growing rapidly, with increasing deployment of AI solutions across hospitals and imaging centers by companies like GE HealthCare and Siemens Healthineers. Usage is measured by the number of imaging studies analyzed. Pricing typically ranges from USD 10,000 to over USD 100,000 annually per solution, depending on features and scale. Subscription and per-scan pricing models are common. Rising imaging volumes and the need for faster, more accurate diagnostics are driving higher adoption and spending.

The Type segment in the AI in Radiology Market is dominated by software, as AI-driven algorithms and platforms form the core of radiology solutions. These software tools enable automated image analysis, anomaly detection, and clinical decision support, significantly improving diagnostic accuracy and workflow efficiency. The increasing volume of imaging data and the shortage of skilled radiologists are key factors driving adoption. While hardware supports imaging infrastructure, and services ensure implementation and maintenance, software remains the primary growth driver due to continuous advancements in AI models and integration capabilities.

Market Segmentation
TypeSoftware, Hardware, Services
ServicesIntegration Services, Maintenance Services, Consulting Services, Training Services
TechnologyMachine Learning, Deep Learning, Natural Language Processing, Computer Vision
ApplicationOncology, Cardiology, Neurology, Musculoskeletal, Respiratory
DeploymentCloud-Based, On-Premise, Hybrid
End UserHospitals, Diagnostic Centers, Research Institutes
SolutionDiagnostic Solutions, Imaging Solutions, Workflow Solutions

The Application segment is led by oncology, driven by the high demand for early and accurate cancer detection. AI-powered radiology solutions are widely used to identify tumors, monitor disease progression, and support treatment planning. Neurology and cardiology are also significant segments, where AI aids in detecting conditions such as stroke and heart disease through advanced imaging analysis. The growing prevalence of chronic diseases and the need for faster, more precise diagnostics are accelerating the adoption of AI in radiology across these application areas.

Geographical Overview

North America holds the largest market share in the AI in Radiology Market due to its advanced healthcare infrastructure, high adoption of medical imaging technologies, and strong integration of artificial intelligence in clinical workflows. The United States leads the region with widespread use of AI-powered tools in CT, MRI, and X-ray interpretation across hospitals and diagnostic centers. Strong presence of leading AI healthcare companies, combined with significant investments in digital health transformation, accelerates adoption. Favorable reimbursement structures, high healthcare expenditure, and supportive regulatory approvals for AI-based diagnostic tools further strengthen North America's dominant position in the global AI in radiology market.

Asia Pacific is expected to register the highest CAGR in the AI in Radiology Market due to rapid digitalization of healthcare systems and increasing demand for efficient diagnostic solutions. Countries such as China, India, Japan, and South Korea are investing heavily in AI-enabled healthcare infrastructure and medical imaging technologies. Rising patient populations, shortage of radiologists, and increasing prevalence of chronic diseases are driving adoption of AI-based radiology tools. Government initiatives supporting smart hospitals and tele-radiology expansion further accelerate growth. Additionally, growing investments from global AI companies and local startups are positioning Asia Pacific as the fastest-growing regional market.

Key Trends and Drivers

Rising demand for faster and more accurate diagnostic imaging

A key driver of the AI in Radiology Market is the increasing need for faster, more accurate, and efficient diagnostic imaging solutions. The growing volume of medical imaging data from CT, MRI, and X-ray scans is overwhelming radiologists, leading to delays and diagnostic errors. AI-powered radiology tools help automate image analysis, detect abnormalities with higher precision, and improve workflow efficiency. These technologies support early disease detection, particularly in oncology, neurology, and cardiovascular conditions. Rising prevalence of chronic diseases and increasing demand for preventive healthcare are further accelerating the adoption of AI-based radiology solutions across global healthcare systems.

Expansion of AI-enabled diagnostic platforms and teleradiology services

A major opportunity in the AI in Radiology Market lies in the expansion of AI-enabled diagnostic platforms and teleradiology services. The integration of artificial intelligence with cloud-based imaging systems allows real-time analysis and remote diagnosis, improving access to healthcare in underserved regions. Increasing adoption of telemedicine and digital hospitals is further driving demand for AI-powered radiology tools. Additionally, advancements in deep learning algorithms and image recognition technologies are enhancing diagnostic accuracy and efficiency. Growing collaborations between healthcare providers, AI companies, and imaging equipment manufacturers are expected to significantly expand market opportunities globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS34515

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type (Software, Hardware, Services)
  • 2.2 Key Market Highlights by Solution (Diagnostic Solutions, Imaging Solutions, Workflow Solutions)
  • 2.3 Key Market Highlights by Services (Integration Services, Maintenance Services, Consulting Services, Training Services)
  • 2.4 Key Market Highlights by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision)
  • 2.5 Key Market Highlights by Application (Oncology, Cardiology, Neurology, Musculoskeletal, Respiratory)
  • 2.6 Key Market Highlights by Deployment (Cloud-Based, On-Premise, Hybrid)
  • 2.7 Key Market Highlights by End User (Hospitals, Diagnostic Centers, Research Institutes)

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software
    • 4.1.2 Hardware
    • 4.1.3 Services
  • 4.2 Market Size & Forecast by Solution (2020-2035)
    • 4.2.1 Diagnostic Solutions
    • 4.2.2 Imaging Solutions
    • 4.2.3 Workflow Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Integration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Consulting Services
    • 4.3.4 Training Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Deep Learning
    • 4.4.3 Natural Language Processing
    • 4.4.4 Computer Vision
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiology
    • 4.5.3 Neurology
    • 4.5.4 Musculoskeletal
    • 4.5.5 Respiratory
  • 4.6 Market Size & Forecast by Deployment (2020-2035)
    • 4.6.1 Cloud-Based
    • 4.6.2 On-Premise
    • 4.6.3 Hybrid
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Solution
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Deployment
      • 5.2.1.7 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Solution
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Deployment
      • 5.2.2.7 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Solution
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Deployment
      • 5.2.3.7 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Solution
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Deployment
      • 5.3.1.7 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Solution
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Deployment
      • 5.3.2.7 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Solution
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Deployment
      • 5.3.3.7 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Solution
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Deployment
      • 5.4.1.7 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Solution
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Deployment
      • 5.4.2.7 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Solution
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Deployment
      • 5.4.3.7 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Solution
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Deployment
      • 5.4.4.7 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Solution
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Deployment
      • 5.4.5.7 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Solution
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Deployment
      • 5.4.6.7 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Solution
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Deployment
      • 5.4.7.7 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Solution
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Deployment
      • 5.5.1.7 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Solution
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Deployment
      • 5.5.2.7 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Solution
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Deployment
      • 5.5.3.7 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Solution
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Deployment
      • 5.5.4.7 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Solution
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Deployment
      • 5.5.5.7 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Solution
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Deployment
      • 5.5.6.7 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Solution
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Deployment
      • 5.6.1.7 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Solution
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Deployment
      • 5.6.2.7 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Solution
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Deployment
      • 5.6.3.7 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Solution
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Deployment
      • 5.6.4.7 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Solution
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Deployment
      • 5.6.5.7 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Siemens Healthineers
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 GE Healthcare
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 IBM Watson Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zebra Medical Vision
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 EnvoyAI
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fujifilm Holdings
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Canon Medical Systems
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Nuance Communications
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 iCAD
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Riverain Technologies
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Qure.ai
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Vuno
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 DeepMind
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 RadNet
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Butterfly Network
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!